News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Human CAR-T Cell Glioblastoma Trial Generates Clues for Improving Treatment

Al's Comment:

 This was too small to tell if the treatment works, but it did prove that these cells can cross the blood brain barrier- which is a major step forward.  CAR-T cell therapy is one of the most exciting new therapies available. Recently the first CAR-T cell therapy for leukemia was approved by the FDA, after trials showing very high long term remission rates after a single injection!


Posted on: 07/19/2017

Human CAR-T Cell Glioblastoma Trial Generates Clues for Improving Treatment

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740